Natco Pharma Q2 Results
- BSE: 524816
- NSE: NATCOPHARM
- ISIN: INE987B01026
- Sector: Biotechnology & Drugs
BSE
952.25
37.25 (4.07%)
37.25 (4.07%)Volume77.35 K
Updated: Thu 13 Aug, 2026 | 15:58:34
NSE
95438.70 (4.23%)
38.70 (4.23%)Volume1.20 M
Updated: Thu 13 Aug, 2026 | 15:29:59
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Natco Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 836.20 | 815.50 | 2.54% | 612.60 | 36.50% |
| Depreciation/ Amortization | 52.40 | 57.60 | -9.03% | 45.80 | 14.41% |
| Operating Income | 526.80 | 513.40 | 2.61% | 758.50 | -30.55% |
| Net Income | 518.40 | 480.70 | 7.84% | 677.30 | -23.46% |
| Other Operating Expenses Total | 413.80 | 355.90 | 16.27% | 237.70 | 74.08% |
| Net Income Before Taxes | 613.70 | 571.90 | 7.31% | 818.20 | -24.99% |
| Total Revenue | 1,363.00 | 1,328.90 | 2.57% | 1,371.10 | -0.59% |
| Selling/ General/ Admin Expenses Total | 200.30 | 169.00 | 18.52% | 151.50 | 32.21% |
| Diluted Normalized EPS | 28.94 | 26.84 | 7.82% | 37.81 | -23.46% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.